The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO GI 2024 | Factors influencing the treatment of hepatocellular carcinoma
David Pinato, MD, PhD, Imperial College London, London, UK, provides insight into how viral and non-viral factors influence liver cancer diagnosis and its aggressiveness. The varying histologies result in different disease burdens, complicating therapeutic choices. He emphasizes the need for a multidisciplinary approach and highlights the importance of navigating treatments based on real-world data and existing evidence in the clinic. This interview took place at 2024 European Society for Medical Oncology (ESMO) Gastrointestinal Cancers Annual Congress in Munich, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
